Alteogen
   
  03 DEC 2014 | NexP™ fusion technology patent registry in EU
  Poster : 박종윤     Date : 15-01-25 08:07     Hit : 417    
ALTEOGEN's patent for NexP™ fusion technology registered in EU on 3rd Dec 2014.


NexP™ fusion technology is a platfrom technology for long-acting therapeutic proteins and peptides.
With NexP™ fusion technology, we can prolong the in-vivo half life of therapeutic proteins and peptides.
NexP™ fusion technology is ALTEOGEN's proprietary technology.